Glaukos (GKOS) Net Shares Issued and Repurchased (2014 - 2025)
Glaukos' (GKOS) quarterly Net Shares Issued and Repurchased came in at $189000.0 in Q4 2025, up 139.24% year-over-year from $79000.0 in Q4 2024, and up 139.24% quarter-over-quarter from $79000.0 in Q4 2024.
Powered by 
Analysis
Glaukos (GKOS) Net Shares Issued and Repurchased (2014 - 2025) Analysis & Trends
Glaukos (GKOS) has reported Net Shares Issued and Repurchased for 12 consecutive years, with $189000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 139.24% year-over-year to $189000.0 in Q4 2025; TTM through Dec 2025 was $189000.0, a 139.24% increase from a year earlier, with the FY2025 full-year figure at $189000.0, up 139.24% from the prior year.
- Net Shares Issued and Repurchased was $189000.0 for Q4 2025 at Glaukos, up from $79000.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $307000.0 in Q4 2023 and troughed at $79000.0 in Q4 2024.
- A 5-year average of $199800.0 and a median of $189000.0 in 2025 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased sank 80.63% in 2021 and jumped 139.24% in 2025, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $142000.0 in 2021, then jumped by 98.59% to $282000.0 in 2022, then gained by 8.87% to $307000.0 in 2023, then tumbled by 74.27% to $79000.0 in 2024, then jumped by 139.24% to $189000.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $189000.0 (Q4 2025), $79000.0 (Q4 2024), and $307000.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | - |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | - |
| 10 | Glaukos | 10.70 Bn | 10.59 Bn | 151.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 189,000.00 |
| Dec 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 307,000.00 |
| Dec 31, 2022 | 282,000.00 |
| Dec 31, 2021 | 142,000.00 |
| Dec 31, 2020 | 733,000.00 |
| Dec 31, 2019 | 186,000.00 |
| Mar 31, 2019 | 103,000.00 |
| Dec 31, 2018 | 896,000.00 |
| Mar 31, 2018 | 743,000.00 |
| Dec 31, 2017 | 1.88 Mn |
| Mar 31, 2017 | 1.40 Mn |
| Dec 31, 2016 | 1.98 Mn |
| Mar 31, 2016 | 1.39 Mn |
| Dec 31, 2015 | 1.14 Mn |
| Dec 31, 2014 | 1.57 Mn |